Repression of Thbs2 greatly contributes to the reduction of fibrosis in the context of pulmonary artery hypertension-induced cardiac injury, indicating the antifibrotic potential of Thbs2 [43–45]. The gene discussed is THBS2; the disease is pulmonary arterial hypertension.